SCHEMBL16355226

SCHEMBL16355226

CCN(CC)c1ccc(NC(=O)c2cccc(COCCOCCOC(=O)N3CCN(CCOCCO)CC3)c2)c(-c2cc(C(=O)NCc3cccc(C(F)(F)F)c3)ccn2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC34A2 O95436 1/20 0.61
HTR2A P28223 3/20 0.37
HTR2C P28335 2/20 0.37
RXFP1 Q9HBX9 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
SCD O00767 1/20 0.35
GPR52 Q9Y2T5 1/20 0.35
SMYD2 Q9NRG4 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
BRAF P15056 3/20 0.34
RAF1 P04049 2/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15432788 1.00 SLC34A2 (0.61) SLC34A2HTR2AHTR2CRXFP1KIT
SCHEMBL18482726 0.90 SLC34A2 (0.56) SLC34A2HTR2AHTR2CRXFP1SCD
SCHEMBL16355227 0.90 SLC34A2 (0.74) SLC34A2SCDGPR52PSEN1PSEN2
SCHEMBL15432793 0.90 SLC34A2 (0.74) SLC34A2SCDGPR52PSEN1PSEN2
SCHEMBL15432786 0.90 SLC34A2 (0.74) SLC34A2SCDGPR52PSEN1PSEN2
SCHEMBL15420848 0.86 SLC34A2 (0.62) SLC34A2HTR2ARXFP1SCDBRAF
SCHEMBL10274256 0.85 SLC34A2 (0.74) SLC34A2HTR2ASCDGPR52PSEN1
SCHEMBL15432798 0.85 SLC34A2 (0.67) SLC34A2SCDGPR52PSEN1PSEN2
SCHEMBL18040406 0.85 SLC34A2 (0.67) SLC34A2SCDGPR52PSEN1PSEN2
SCHEMBL15432789 0.85 SLC34A2 (0.67) SLC34A2SCDGPR52PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9301951-B2 Compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2016-04-05 US disclosed
US-20150164876-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2015-06-18 US disclosed
US-8916569-B2 Compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2014-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164876-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A2, SLC34A1, SLC10A2 SLC34A2 1/4885HTR2A 1684/4885HTR2C 2639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.